Results for tag: "Kappa Antagonist"

Kappa Antagonists are a class of drugs used to treat a variety of central nervous system disorders, including depression, anxiety, and schizophrenia. These drugs work by blocking the action of the neurotransmitter kappa-opioid receptor, which is involved in the regulation of mood and emotion. By blocking this receptor, kappa antagonists can reduce the symptoms of these disorders. Kappa antagonists are typically prescribed as part of a comprehensive treatment plan, which may include psychotherapy, lifestyle changes, and other medications. They are generally well-tolerated and have few side effects. The kappa antagonist market is a growing segment of the central nervous system drug market. It is expected to continue to expand as more people are diagnosed with mental health disorders and as new treatments become available. Some companies in the kappa antagonist market include Allergan, Eli Lilly, Johnson & Johnson, Merck, and Pfizer. Show Less Read more